-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicare-medication-use_research.pdf
April 01, 2014 - We determined whether they
had a psychiatric or a selected medical
diagnosis during the reference year … (including prescription drugs) during the
most recent month of dual eligibility for
the reference year … Nonduals had Medicare coverage only
for the reference year.23
Part D Status: We categorized Part D … All Part D indicates
continuous Part D coverage during the
reference year for all months of Medicare … No
Part D indicates no Part D coverage
during the reference year.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/weight-loss-surgery_research-protocol.pdf
December 14, 2010 - Short-term outcomes: 1 year or best available post surgery intervention. … Short-term outcomes: 1 year or best available post surgery or medical
intervention. … Comparators:
N/A
Outcomes:
Short-term adverse events:
• mortality
• other
Timing:
1 year … How do they compare to short-term outcomes (within 1 year from
surgery)? … A 10-year Experience with Laparoscopic
Gastric Banding for Morbid Obesity: High Long-Term Complication
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/masks-appendix-table-b-3-version-1.xlsx
February 01, 2020 - Observational studies of masks in healthcare settings
Author Publication Year Title Date Retrieved Source
-
effectivehealthcare.ahrq.gov/sites/default/files/adhd_disposition-comments.pdf
October 01, 2011 - The analysis by Zuvekas showed a slight change
from 97 to 01—a five year period in comparison to the … 10 year earlier
steeper change. … Rewritten, Adderall is approved for ≥3 year olds
in USA, and ≥6 year olds in Canada p 27 of 278
Peer … data was not seen later in
the 8 year data. … By 3 year, MTA
showed no difference among interventions but all improved from
baseline.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-future_research.pdf
April 01, 2013 - (I, O)
• What is the long-term (>1 year) effectiveness of pharmacologic treatments for prevention of … (I, O)
• What is the long-term (>1 year) effectiveness of pharmacologic treatments for prevention of … Population Adults with chronic migraine maintaining preventive treatment regimen for 1 year. … Intervention Preventive pharmacologic treatment of 1-year duration. … How many migraine patients need
prolonged (>1 year) preventive treatment?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/disparities-quality-improvement_executive.pdf
August 01, 2012 - term among minorities than among Whites, although the
interaction was no longer significant after 1 year … Summary of effects on disparities in health outcomes associated with race or
ethnicity
Author, Year … Summary of effects on disparities in health outcomes associated with insurance
status
Author, Year, … Summary of effects on disparities in health outcomes associated with sex
Author, Year, Study
Design … Duration of studies was generally 1 year.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/child-growth-development-outcomes-protocol-amended.pdf
November 18, 2024 - nutrition for infants is commercially
prepared and regulated standard infant formula during the first year … cow milk, regardless of milk fat content, should not be
included in an infant’s diet until after 1 year … Excel® for data extraction for each Key
Question that includes study characteristics (e.g., author, year
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/making-healthcare-safer-IV.pdf
August 04, 2023 - In the United States,
more than 2.8 million antimicrobial-resistant infections occur each year and … a
comparison group, including
pre-post studies), systematic
reviews, published since 2019,
the year … We will search PubMed and the Cochrane Library for systematic reviews published since 2019,
the year … a single team member to confirm eligibility and prepare a summary of the study,
including author, year … describe eligible systematic reviews, a single team member will prepare a summary including
the author, year
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-illness-disparities_research-protocol.pdf
July 01, 2015 - Among adults with an SMI in
2008, less than 60 percent had used mental health services in the previous year … What are potential long-term (10-year +) developments in this field?
III. Methods
1. … Inclusion Exclusion
Population All GQs
§ ≥ 18 years with SMIa currently or at any time during the past
year … The following information will be obtained from each study, where
applicable: author, year of publication
-
effectivehealthcare.ahrq.gov/sites/default/files/politi.pdf
May 29, 2025 - multiple comorbidities
• Colorectal Cancer Screening Options for patients over age 7 or with
< year
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_surveillance.pdf
July 01, 2012 - Evidence Table
Article ID,
Author, year
Trial n Subjects Primary
Outcome
Duration Study Quality … -raloxifene (60
mg/day): 9.754
Postmenopausal
women age >35
years, with a 5- year … -tamoxifen (20
mg/day): 9,736
-raloxifene (60
mg/day): 9.754
Postmenopausal
women with a 5-
year … :
2285
-placebo: 2275
Postmenopausal
women age > 35
with one of the
following factors: a
5- year … -tamoxifen (20
mg/day): 4739
-raloxifene (60
mg/day): 4717
Postmenopausal
women with a 5-
year
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicidal-thoughts-young-people-amendement.pdf
February 05, 2025 - We will limit the literature search to studies published after the year 2000 as
older studies may not … Publications • Full-text peer-reviewed studies published in English
• Studies published after the year … Registrar of Controlled Trials, Ovid® Cochrane Database of Systematic Reviews, and Scopus®
from the year … we will develop a standardized data extraction form to
extract study characteristics (i.e., author, year
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-3-noninvasive-nonpharma_0.xlsx
January 01, 2022 - surveillance reports for noninvasive nonpharmacological treatment for chronic pain report
Author, Year … history of metastasizing cancer, unexplained unintended weight loss of 20 lbs. or more in the past year … B
Age: 51 vs. 54 years
Female: 94.7% vs. 100%
Year since diagnosis: 8.16 vs. 8.98 years
Baseline VAS … C
Age: 52 (7.2) vs. 55 (7.2) vs. 56 (8.8)
%Female: 100 vs. 100 vs. 100
Year of diagnosis: 2001 (7.5) … B
Age: 53 (8) vs. 52.7 (8.5)
%Female: 73 (97.3) vs. 74 (98.7)
Year of diagnosis: 14 (9) vs. 13.1 (9.7
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_executive.pdf
January 01, 2015 - Five of the included
observational studies lasted 1 year or less. … Of the 96 trials, 33 were at
least 1 year in duration. … Most RCTs lasted a year or less, with only
about 5 percent lasting more than 2 years. … Risk of stroke with
thiazolidinediones: a ten-year nationwide population-based cohort
study. … Three-year efficacy of
complex insulin regimens in type 2 diabetes.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-195-uterine-fibroids-final.pdf
December 01, 2017 - $5 billion, perhaps as much as $17 billion,
with roughly $4,624 in costs per woman in
the first year … These are rare
but ominous: an average of 1,600 new cases occur in the
United States each year. … They have poor outcomes with
an average 5-year survival of 36 percent if cancer is not
isolated to … Our models included the
effect of the mean age of women in each study and the
year in which it was … One small study reported improved bleeding
patterns one year after surgery in 12 of 15 women.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioid-treatments-chronic-pain-protocol.pdf
December 19, 2018 - effectiveness and risks of opioid therapy for
chronic pain, focusing on studies with long-term (≥1 year … long-term opioid therapy for chronic pain, due to the
absence of trials with followup of at least 1 year … up to 6 months), intermediate-term follow-up (6 to 12
months), and long-term follow-up (at least 1 year … up to 6 months), intermediate-term follow-up (6 to 12 months), and long-
term follow-up (at least 1 year … up to 6 months),
intermediate-term follow-up (6 to 12 months), and long-term follow-up (at least 1
year
-
effectivehealthcare.ahrq.gov/sites/default/files/epc-disclosure-policy-form.pdf
March 01, 2023 - Time period for financial interests disclosure: The instructions recommend a two year time window: 12 … For example, if financial COI from all
sources over a two year time window (within the past year and … For example, if financial COI from all sources over a two year time window (within the past year and … Time period for financial interests disclosure: The instructions recommend a two year time window: 12 … For example, if financial COI from all sources over a two year time window (within the past year and
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-194-disposition-comments-inhaled-corticosteroids.pdf
March 19, 2018 - Nonetheless the overall trend is
increasing (despite year to year
differences in direction and
amount … Public reviewer
#1, Anonymous
Time frame of the study (weeks, time of year)
would also be informative … comparing it to high dose
corticosteroid the evidence is week that it is a
better choice in 5-11 year … As a pediatric asthma
clinician, I found the discussion on the 0-4 year
old use of intermittent ICS … found it difficult to understand whether there
were sufficient numbers and evidence in the 12-
17 year
-
effectivehealthcare.ahrq.gov/sites/default/files/frazee-presentation.pdf
May 29, 2025 - pay the mortgage, and your kids stil l have to get ready for school, and
you find out that your 15-‐year … They schedule my
cleanings twice
a year. Ninety-‐nine percent of the time I show up. … something new with
a patient for a short period
of
time. did a research study earlier this year
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-2.xlsx
September 30, 2015 - Randomized controlled trials
Author, Year Study Design
Duration Setting
Country Eligibility Criteria … Observational studies
Author, Year Type of Study, Setting Eligibility Criteria Comparison Groups Population … vs 66.1
Baseline MME ≥150: 46.7 vs. 34.0
Benzodiazepine use: 29.6% vs. 37.5%
No overdoses previous year … electronic medical records, ICD-9 CM codes Enrolled: 1,320
Analyzed: 1,320
Loss to followup: NA Age, sex, year